Join Ultimovacs ASA for Q3 2024 Results Presentation
Oslo: Ultimovacs ASA (OSE: ULTI), a forward-thinking clinical-stage biotechnology company, specializes in the development of innovative immunotherapeutic cancer vaccines. We are excited to announce an upcoming event where Ultimovacs will share its results for the third quarter of 2024.
Webcast Details for Investors and Stakeholders
On the scheduled date, participants can tune in to the live webcast presentation at 14:00 CET. The webcast will be seamlessly accessible through the official Ultimovacs website. This presentation offers a unique opportunity for stakeholders to gain insights into the company's latest developments and financial performance.
Interactive Session for Questions
The webcast will feature an interactive component, allowing viewers to pose questions during the presentation, ensuring a dynamic exchange of ideas and information. This is an excellent chance for investors and interested parties to engage directly with Ultimovacs' leadership.
Report Availability and Resources
For those interested in detailed financials and further insights, the full report and presentation materials will be available on the Ultimovacs website from 07:00 CET on the day of the event. This proactive approach ensures that all stakeholders are well-informed ahead of the live session.
Meet the Leadership Team
During the presentation, attendees will hear from the company’s key leaders:
Carlos de Sousa, CEO
Email: carlos.desousa@ultimovacs.com
Phone: +47 908 92507
Hans Vassgård Eid, CFO
Email: hans.eid@ultimovacs.com
Phone: +47 482 48632
About Ultimovacs ASA
As a leader in the biotechnology sphere, Ultimovacs is committed to pioneering treatments that harness the body's immune system to fight cancer. Their approach is not just cutting-edge; it represents hope for many patients facing various forms of cancer.
Frequently Asked Questions
What is the date of the Q3 2024 webcast presentation?
The webcast presentation is scheduled for November 6, 2024.
How can I access the webcast?
The presentation can be accessed through the Ultimovacs website starting at 14:00 CET.
Will there be a Q&A during the webcast?
Yes, attendees will have the opportunity to ask questions during the presentation.
Where can I find the report and presentation materials?
The report and presentation materials will be available on the Ultimovacs website from 07:00 CET on the day of the presentation.
Who can I contact for more information?
For queries, you can reach out to Carlos de Sousa or Hans Vassgård Eid through the provided email or phone contacts.